H1 secures $40M from CVS, proving SaaS startups can still attract investment

H1, a healthcare data platform, raised $40 million in a round led by CVS Health Ventures.

The nine-year-old company said it was already cash flow and EBITDA profitable and not actively fundraising.

CEO Ariel Katz said data-focused SaaS businesses may be harder for AI tools to replace than workflow software.

The deal highlights continued interest in profitable SaaS and corporate venture backing for healthcare data infrastructure.